Save the date

Join us this September 23–25 in Berlin for the fifth edition of RExPO, Europe’s leading conference in the intersection of systems medicine, network pharmacology, Artificial Intelligence and drug repurposing.

RExPO26 brings together clinicians, researchers, industry leaders, SMEs, patient organizations, regulators, payers and policymakers to shape the next generation of mechanism-based precision therapeutics.

Choose your spot

EARLY BIRD PRICES

Registration will open soon – stay tuned!

GENERAL ADMISSION

FULL PASS

400 EUR

GENERAL ADMISSION

2-DAY PASS

360 EUR

GENERAL ADMISSION

DAY PASS (LIMITED)

210 EUR

START-UPS

FULL PASS

300 EUR

START-UPS

2-DAY PASS

260 EUR

START-UPS

DAY PASS (LIMITED)

150 EUR

ACADEMIA

FULL PASS

250 EUR

ACADEMIA

2-DAY PASS

210 EUR

ACADEMIA

DAY PASS (LIMITED)

130 EUR

PHD STUDENTS

FULL PASS

150 EUR

PHD STUDENTS

2-DAY PASS

130 EUR

PHD STUDENTS

DAY PASS (LIMITED)

90 EUR

PATIENTS & PATIENT ORGANISATIONS

FULL PASS

75 EUR

PATIENTS & PATIENT ORGANISATIONS

2-DAY PASS

65 EUR

PATIENTS & PATIENT ORGANISATIONS

DAY PASS (LIMITED)

40 EUR

Conference tracks

Unmet medical needs in cancer

Unmet medical needs in neurological diseases

The REMEDi4ALL sister project

Innovation in drug development & repurposing

Network medicine approaches to adverse drug event prediction for new & repurposed drugs

Translating to the global market

AI/ML in systems medicine & drug repurposing

Fostering mechanism-based repurposing around the globe

REPO4EU's drug repurposing platform

The last mile: accessibility for patient benefit

Computational drug repurposing

The role of IP in the drug repurposing business case

The patients' voice and patient-centricity

What are you waiting for?

Meet a vibrant community of researchers, clinicians and innovators that are redefining precision medicine from mechanism to patient impact.

OUR SPEAKERS

Our call for abstracts is now open

If your abstract is selected, you’ll have the chance to present your work either during our dedicated Poster Sessions or as one of the conference’s Main Talks.

KEY TOPICS

REPO4EU's drug repurposing platform

Don't miss the official launch of our platform's beta version, first live presentation and hands-on demonstration.

LEARN MORE

The EU drug repurposing ecosystem

Meet all the major initiatives in drug repurposing (including REPO4EU, REMEDi4ALL and RePo-SUDOE) in one place.

LEARN MORE

Rare diseases & precision therapeutics

New translational strategies for rare and ultra-rare diseases, from mechanism discovery to targeted intervention.

LEARN MORE

The Network Medicine Alliance

Systems-level approaches to disease mechanisms, patient stratification and therapeutic innovation, plus a keynote lecture by Joseph Loscalzo, one of the founding figures of Network Medicine.

LEARN MORE

Generative AI & real-world applications

Gen AI use cases in systems medicine, biomarker discovery, hypothesis generation and clinical decision support.

LEARN MORE

Clinical trial validation & PoC studies

First validation results from REPO4EU-associated clinical studies and translational pilots.

LEARN MORE

Open Science, publishing & data sharing

New models for transparent science, FAIR data and dissemination in biomedical publishing.

LEARN MORE

IP strategy, reimbursement & sustainable market access

From intellectual property frameworks to payer acceptance, pricing and long-term implementation.

LEARN MORE

Useful information for attendees

Where will the conference take place?

RExPO26 will be held at Futurium. The venue’s full address is: Alexanderufer 2, 10117 Berlin, Germany.

Check it out

How do I get in touch?

For any topic related to RExPO26, please feel free to contact the conference office. We will be happy to help – you can reach us directly via email.

Contact us

000 days 00 hours 00 minutes 00 seconds

UNTIL RExPO26

In collaboration with...

Our Platinum Sponsor

Buchanan’s Life Sciences Industry Group offers a rare and comprehensive mix of FDA Regulatory, Intellectual Property, Litigation and Government Relations services delivered through one seamless team. They counsel clients on the full range of issues that arise during the product lifecycle, from idea conception to commercialization. Their clients, which include leading pharmaceutical companies, biotechnology companies, wholesalers and distributors, retailers, industry trade associations and leading research institutions, trust Buchanan Life Sciences with their most challenging business and legal problems.